In 2019, Nam reported that the gene signature related to DNA methylation differs between primary RCC and RCC metastases, as it was found, that metastatic tumours often demonstrated more pronounced changes compared to primary tumours, e.g., in metabolism-related HK2 and SZC16A3 [148]. The gene discussed is HK2; the disease is neoplasm.